A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.


Updates from The Motley Fool

Latest updates on NuVasive from Fool.com.


Stock Performance

NUVA vs. S&P 500 | 2 Year Performance
View Interactive NUVA Charts
Sponsored by

Key Data Points

Primary metrics and data points about NuVasive.
Current Price: $65.75
Prev Close: $67.31
Open: $67.19
Bid: $55.91
Ask: $72.00
Day's Range: $65.13 - $67.19
52wk Range: $36.81 - $69.00
Volume: 475,561
Avg Vol 733,373
Market Cap: $3.23B
P/E (ttm): 70.11
EPS (ttm): $0.96
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NuVasive.
CAPS Rating 5 out of 5
 
253 Outperform
16 Underperform
CAPS All Stars
 
55 Outperform
3 Underperform

How do you think NuVasive will perform against the market?



You pick for NuVasive is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Greg Lucier, CEO

97% Approve

Based on 15 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NuVasive.

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT